WC
PFE icon

Westhampton Capital’s Pfizer PFE Stock Holding History

Westhampton Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1,000K Sell
41,508
-350
-0.8% -$9.15K 0.41% 63
2026
Q1 		$1.18M Hold
41,858
– – 0.55% 55
2025
Q4 		$1.04M Sell
41,858
-750
-2% -$18.9K 0.49% 60
2025
Q3 		$1.09M Sell
42,608
-4,170
-9% -$103K 0.53% 57
2025
Q2 		$1.13M Buy
46,778
+4,200
+10% +$97.9K 0.59% 54
2025
Q1 		$1.08M Buy
42,578
+400
+0.9% +$10.5K 0.59% 57
2024
Q4 		$1.12M Buy
42,178
+500
+1% +$13.6K 0.57% 57
2024
Q3 		$1.21M Buy
41,678
+9,900
+31% +$289K 0.61% 55
2024
Q2 		$889K Buy
31,778
+525
+2% +$14.5K 0.48% 65
2024
Q1 		$867K Buy
31,253
+5,100
+20% +$142K 0.47% 65
2023
Q4 		$753K Sell
26,153
-300
-1% -$9.07K 0.45% 68
2023
Q3 		$877K Sell
26,453
-150
-0.6% -$5.3K 0.57% 59
2023
Q2 		$976K Sell
26,603
-330
-1% -$12.8K 0.63% 52
2023
Q1 		$1.1M Buy
26,933
+100
+0.4% +$4.32K 0.71% 50
2022
Q4 		$1.37M Buy
26,833
+500
+2% +$24K 0.93% 42
2022
Q3 		$1.15M Hold
26,333
– – 0.87% 43
2022
Q2 		$1.38M Buy
26,333
+300
+1% +$15.3K 0.98% 36
2022
Q1 		$1.35M Hold
26,033
– – 0.87% 40
2021
Q4 		$1.54M Hold
26,033
– – 0.94% 37
2021
Q3 		$1.12M Sell
26,033
-198
-0.8% -$8.77K 0.77% 44
2021
Q2 		$1.03M Buy
26,231
+250
+1% +$9.72K 0.67% 50
2021
Q1 		$941K Buy
25,981
+2,400
+10% +$85.2K 0.65% 49
2020
Q4 		$868K Buy
23,581
+97
+0.4% +$3.56K 0.65% 48
2020
Q3 		$818K Buy
23,484
+237
+1% +$8.31K 0.67% 48
2020
Q2 		$721K Sell
23,247
-432
-2% -$14.7K 0.63% 49
2020
Q1 		$733K Hold
23,679
– – 0.76% 43
2019
Q4 		$880K Sell
23,679
-274
-1% -$9.76K 0.71% 43
2019
Q3 		$817K Sell
23,953
-42
-0.2% -$1.53K 0.68% 45
2019
Q2 		$986K Buy
+23,995
New +$953K 0.83% 39

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westhampton Capital's PFE Position: Q2 2026 in Review

Westhampton Capital reduced its Pfizer (PFE) stake by 0.84% in Q2 2026, selling an estimated $9.15K and leaving 41,508 shares worth $1,000K. The position accounts for 0.41% of the portfolio, ranked #63.

Westhampton Capital first reported a position in PFE in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.54M in Q4 2021. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Westhampton Capital held 41,508 shares of Pfizer worth $1,000K as of Q2 2026.
  • Westhampton Capital sold 350 Pfizer shares in Q2 2026, an estimated $9.15K.
  • Pfizer made up 0.41% of Westhampton Capital's portfolio in Q2 2026, its #63 holding.
  • Westhampton Capital first reported a position in Pfizer in Q2 2019 and has held it in 29 quarters since.
  • Westhampton Capital's Pfizer position peaked at $1.54M in Q4 2021.
  • 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Westhampton Capital's 13F filing for Q2 2026, filed 14 Jul 2026.